ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.96
0.71%
US Tech 100
20,762.73
1.73%
S&P 500
5,942.47
1.26%
US Dollar vs CAD
1.44457
0.00%
Bitcoin
98,323.83
0.12%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Oncoclinicas Brasil Servicos Medico (ONCO3) Share Price

Oncoclinicas Brasil Servicos Medico

Oncoclinicas Brasil Servicos Medico (ONCO3)

BOV
2.45
0.08
(3.38%)
Closed January 05 2:55PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.45
Bid
2.40
Ask
2.46
Volume
7,104,000
2.33 Day's Range 2.57
1.93 52 Week Range 12.76
Market Cap
1.292B
Previous Close
2.37
Open
2.37
Last Trade
2000
@
2.45
Last Trade Time
Financial Volume
R$ 17,276,928
VWAP
2.432
Average Volume (3m)
8,048,533
Shares Outstanding
527,481,598
Dividend Yield
-
PE Ratio
5.76
Earnings Per Share (EPS)
0.42
Revenue
5.5B
Net Profit
223.62M

About Oncoclinicas Brasil Servicos Medico

Sector
Offices-holdng Companies,nec
Industry
Gen Med & Surgical Hospitals
Website
grupooncoclinicas.com
Headquarters
Sao Paulo, Sao Paulo, Bra
Founded
2010
Oncoclinicas Brasil Servicos Medico is listed in the Offices-holdng Companies sector of the Brazil Bovespa Exchange with ticker ONCO3. The last closing price for Oncoclinicas Brasil Serv... ON was R$2.37. Over the last year, Oncoclinicas Brasil Serv... ON shares have traded in a share price range of R$ 1.93 to R$ 12.76.

Oncoclinicas Brasil Serv... ON currently has 527,481,598 shares outstanding. The market capitalization of Oncoclinicas Brasil Serv... ON is R$1.25 billion. Oncoclinicas Brasil Serv... ON has a price to earnings ratio (PE ratio) of 5.76.

Ask ADVFN Intelligence (AI)

ONCO3 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3717.78846153852.082.732.08117525002.36985067CS
4-0.72-22.71293375393.173.341.9983241812.53921109CS
12-2.06-45.67627494464.514.981.9380485332.97435479CS
26-3.99-61.95652173916.448.361.9360623834.34031673CS
52-9.97-80.273752012912.4212.761.9351388675.91538967CS
156-8.8-78.222222222211.25131.9329300317.14042981CS
260-15.85-86.612021857918.319.621.9327940997.57284023CS

ONCO3 - Frequently Asked Questions (FAQ)

What is the current Oncoclinicas Brasil Serv... ON share price?
The current share price of Oncoclinicas Brasil Serv... ON is R$ 2.45
How many Oncoclinicas Brasil Serv... ON shares are in issue?
Oncoclinicas Brasil Serv... ON has 527,481,598 shares in issue
What is the market cap of Oncoclinicas Brasil Serv... ON?
The market capitalisation of Oncoclinicas Brasil Serv... ON is BRL 1.25B
What is the 1 year trading range for Oncoclinicas Brasil Serv... ON share price?
Oncoclinicas Brasil Serv... ON has traded in the range of R$ 1.93 to R$ 12.76 during the past year
What is the PE ratio of Oncoclinicas Brasil Serv... ON?
The price to earnings ratio of Oncoclinicas Brasil Serv... ON is 5.76
What is the cash to sales ratio of Oncoclinicas Brasil Serv... ON?
The cash to sales ratio of Oncoclinicas Brasil Serv... ON is 0.23
What is the reporting currency for Oncoclinicas Brasil Serv... ON?
Oncoclinicas Brasil Serv... ON reports financial results in BRL
What is the latest annual turnover for Oncoclinicas Brasil Serv... ON?
The latest annual turnover of Oncoclinicas Brasil Serv... ON is BRL 5.5B
What is the latest annual profit for Oncoclinicas Brasil Serv... ON?
The latest annual profit of Oncoclinicas Brasil Serv... ON is BRL 223.62M
What is the registered address of Oncoclinicas Brasil Serv... ON?
The registered address for Oncoclinicas Brasil Serv... ON is AVENIDA PRESIDENTE JUSCELINO KUBITSCHEK N 510, SAO PAULO, SAO PAULO, 04543-906
What is the Oncoclinicas Brasil Serv... ON website address?
The website address for Oncoclinicas Brasil Serv... ON is grupooncoclinicas.com
Which industry sector does Oncoclinicas Brasil Serv... ON operate in?
Oncoclinicas Brasil Serv... ON operates in the GEN MED & SURGICAL HOSPITALS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AZEV11Azevedo Travassos Sa
R$ 0.28
(47.37%)
42.2k
JFEN3Joao Fortes Engenharia Sa
R$ 2.71
(18.34%)
239.56k
VLID3Valid Solucoes E SV De SEG EM Meios
R$ 25.00
(16.28%)
749.17k
AERI3Aeris Industria E ComerciodeEquipamentos paraGeracaodeEnergiaS.A
R$ 7.94
(13.43%)
935.03k
PINE3Banco Pine SA
R$ 4.94
(12.02%)
13.1k
COCE11Cia Energetica Ceara Coelce
R$ 0.62
(-35.42%)
10.7k
RADL3QRaia Drogasil SA
R$ 21.46
(-11.07%)
138k
AALR3Allianca Saude e Participacoes S.A.
R$ 7.27
(-9.13%)
67.2k
OFSA3Ourofino S.A
R$ 16.01
(-8.83%)
6.9k
FICT3Fictor Alimentos S.A.
R$ 3.03
(-8.18%)
39.3k
POMO4Marcopolo Sa
R$ 7.35
(-4.05%)
24.33M
CMIN3CSN Mineracao S.A
R$ 4.88
(-3.17%)
19.02M
ITUB4Itau Unibanco Holding SA
R$ 29.82
(-2.45%)
14.89M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.10
(-3.23%)
13.92M
PETR3Petroleo Brasileiro S.A. Petrobras
R$ 40.38
(-0.35%)
12.65M

Discussion

View Full Feed
mining101 mining101 1 minute ago
Superb
MEGL
benz280c benz280c 8 minutes ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 15 minutes ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 16 minutes ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 19 minutes ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 24 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 25 minutes ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 30 minutes ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 32 minutes ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 33 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 35 minutes ago
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 38 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 41 minutes ago
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 41 minutes ago
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 42 minutes ago
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 44 minutes ago
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 45 minutes ago
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 59 minutes ago
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 1 hour ago
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII
Jane1999 Jane1999 1 hour ago
Here the CEO : https://www.wsj.com/market-data/quotes/CA/XCNQ/TWOH/company-people/executive-profile/149699
TWOH
Curious Bystander Curious Bystander 1 hour ago
The Expert Market was set up by the SEC for several very specific reasons. But you could generally say that a security lands in that market when a company is either UNABLE or UNWILLING to file certain SEC-required forms.

UNABLE or UNWILLING. Hmmmm…..I wonder which category Quantum
FLCX
CometNebula81 CometNebula81 1 hour ago
What is everyone's opinion on if or when dividends may be restored and if so what much would we be looking at in dividends? Let's you have 100,000 shares what would you be getting every year?
FNMA
Steady_T Steady_T 1 hour ago
Wouldn't the MABS have to be better than donepezil and memantine to get approved making them the new SOC?

That doesn't mean the MABS are selling well.
AVXL

Your Recent History

BOV
ONCO3
Oncoclinicas Brasil Serv... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads